Medicine - Medicine News Xagena

Headlines

Health Canada

MHRA

MedSafe

Medicine

News

Drugs

Xagena

AZ Guide

Xapedia

Drugs

Medicine

Italy

Photo Gallery

Abbott, ADHD drug is being discontinued

Osteoporosis, FDA approves once-monthly Ibandronate

Finasteride may prevent prostate cancer

Obstructive sleep apnea and risk of sudden death from cardiac causes

Coronary heart disease, high-versus low dose Atorvastatin

Public Citizen petitions FDA to withdraw Abbott’s Cylert

Epilepsy drug Valproate during pregnancy may increase the risk of severe birth defects

Nesiritide increases the risk of worsening renal function in patients with ADHF

Avonex associated with cases of severe liver damage

New warning for Xigris, a sepsis drug

Role of anti-hepatitis C virus treatment in patients with B-cell non-Hodgkin's lymphoma and HCV infection

Cholesterol affects tumor survival

Smoking may be a risk factor for progression of multiple sclerosis

BNP is a strong prognostic indicator in patients with heart failure

FDA approves Symlin, new diabetes drug

Parecoxib and Valdecoxib, increased cardiovascular events after CABG

Aliskiren, a novel renin inhibitor in hypertension

FDA approves Temodar as treatment for glioblastoma multiforme

Vitamin E can increase the risk for heart failure

Lung cancer, Avastin extends survival

Autoantibody formation in patients with rheumatoid arthritis treated with Infliximab

Rasagiline as an adjunct to Levodopa in patients with Parkinson's disease and motor fluctuations

Risk factors for preeclampsia

Aripiprazole for maintaining efficacy in bipolar I disorder

Two atopic dermatitis drugs should be used cautiously

Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin’s lymphoma

Bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

Non-diabetic proteinuric nephropathies, add-on therapy provides no benefit

Addition of Clopidogrel to Aspirin and fibrinolytic therapy proves beneficial for myocardial infarction

Celecoxib inhibits prostate cancer growth

ADRAC : bisphosphonates and osteonecrosis of the jaw

APC study, cardiovascular risk associated with Celecoxib

Efficacy of Lenalidomide in relapsed or refractory multiple myeloma

WHO: public health concern on acrylamide in food

Genetic variants in UBQLN1 increase the risk of Alzheimer’s disease

Diabetes increases liver cancer risk

Alzheimer’s disease could be a neuroendocrine disorder

FDA has approved Pegasys and Copegus for the treatment of chronic hepatitis C in HIV patients

Thalidomide attenuates weight loss and wasting in pancreatic cancer

European Union, Pegasys approved for the treatment of chronic hepatitis B

Low-dose Aspirin prevents strokes in women

Peginterferon alfa-2a plus Ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Drug-eluting stent: Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis

Recombinant activated factor VII in acute intracerebral haemorrhage

FDA has approved Candesartan Cilexetil for the treatment of heart failure

Treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg is supported by strong evidence

A to Z Trial , Z phase : Simvastatin did not achieve the prespecified end point

ACTION trial : addition of Nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival

Alzheimer’s drugs, NICE proposes to withdraw from NHS

Therapeutic vaccine shows promise in men with prostate cancer

Prostate cancer, vitamin E could cut the risk

Dietary fiber intake reduces blood pressure in patients with hypertension

FDA: Crestor, favorable risk/benefit ratio

Use of Cannabis may lead to psychotic symptoms

Folate and vitamin B12 can reduce the risk of hip fracture in elderly patients following a stroke

Multiple Sclerosis, Tysabri withdrawn from market

Guidelines on use of Antiretroviral Drugs to prevent HIV infection after sexual, drug use, and accidental exposure

Linezolid and neuropathy

Reports of lymphoma and skin cancer in patients treated with Elidel cream

EMEA, regulatory actions for the COX-2 inhibitor

New Warning on Depo-Provera Contraceptive Injection

NCI has stopped a clinical trial of the Cox-2 Inhibitor Celebrex

Bextra, boxed warning concerning severe skin reactions and warning regarding cardiovascular risk

Warning on lymphoma risk with TNF blockers

Treatment for patients with the metabolic syndrome

Vioxx, increased risk of heart attack and stroke

Potential adverse effects of SSRIs and other anti-depressants on newborns

Valdecoxib, severe cutaneous reactions

Pagine successive « 21 22 23 24 25 26 27 28 [29]

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

Annunci Google:

n Xagena.it

Powered by Luca Malattia - LM Web Solutions